Hemophilia: Treatment, New Therapeutics and Optimal Outcomes


Date
Friday, July 15, 2016 - Saturday, July 15, 2017 12:00 AM   Online, IN

Objectives
  1. List at least 2 acute and 2 chronic health complications experienced by a patient with hemophilia
  2. Discuss the impact of comprehensive care on patients’ overall morbidity and mortality.

Accreditation

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Indiana University School of Medicine and IU Health Physicians. Indiana University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians

Indiana University School of Medicine designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Indiana University School of Medicine (IUSM) must demonstrate balance, independence, objectivity, and scientific rigor.  All faculty, authors, editors, and planning committee members participating in an IUSM-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity. 

The planning committee and those in a position to control the content of this activity have disclosed no relevant financial relationships.